Atropos Health, the Palo Alto, Calif.-based healthcare startup, announced a new partnership with Google Cloud today. The collaboration allows Atropos to optimize its Generative Evidence Acceleration Operating System (GENEVA OS) to work with Google Cloud’s healthcare data tools.
“Google Cloud’s real time capabilities align perfectly with our delivery model to the clinicians and researchers who rely on the Atropos Evidence Network,” said Dr. Brigham Hyde, CEO and co-founder of Atropos Health, in an interview with VentureBeat, referring to the access to more than 160 million patients’ de-identified medical data that the company offers. “The partnership will enable data sets hosted in Google Cloud to join the Atropos Evidence Network seamlessly.”
In short, the integration will help health systems and pharmaceutical companies generate insights from their data almost instantly. While other healthcare AI solutions can take months to produce actionable insights, Atropos claims its new generative AI application called ChatRWD will provide answers in minutes using natural language queries.
“ChatRWD represents an evolutionary jump in the speed by which evidence can be generated coupled with seamless user experience,” Hyde told VentureBeat. “Unlike other NLP tools, ChatRWD includes a chat interface to go directly from questions to novel real-world evidence studies using deidentified patient data.”
A strategic alliance for data-driven healthcare
The partnership exemplifies a growing trend of healthcare organizations teaming up with big tech companies to unlock value from their troves of patient data. While data privacy and security remain top concerns, Atropos states they take rigorous measures to protect customer data within Google Cloud’s secure infrastructure.
This allows health systems to redirect resources from maintaining servers to leveraging insights for operational and clinical improvements. Use cases include optimizing formularies (drugs), reducing length of stay, accelerating research, and enabling evidence-based shared decision making for patients.
Fueling global expansion and clinical impact
For Atropos, the collaboration accelerates their mission to close evidence gaps in medicine worldwide. Along with the Google Cloud partnership, the company recently raised an undisclosed amount in strategic financing from Presidio Ventures, the venture arm of Sumitomo Corporation Venture Group, and Samsung Next, a venture arm of Samsung Electronics, among others.
“The best part about working in this company is every single day, there’s a new question that comes in, which is going to have a massive impact on a patient,” Hyde told VentureBeat. “It’s so exciting and this announcement is another step to increasing that impact on medicine.”
As artificial intelligence continues disrupting the $4 trillion healthcare sector, Atropos Health’s innovations showcase how AI and cloud can make evidence-based care more accessible. With lives on the line, the speed and accuracy provided by these technologies could greatly improve clinical decision making and patient outcomes.
VentureBeat’s mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Discover our Briefings.